NDC 75929-055 - Hyoscyamine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 75929-055
- Package NDCs from labels
- 75929-055-10
- Manufacturer
- Pharma Packaging Solutions, LLC dba Tjoapack LLC | Sovereign Pharmaceuticals, LLC
- Effective date
- 2023-08-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hyoscyamine - Pharma Packaging Solutions, LLC dba Tjoapack LLC | Sovereign Pharmaceuticals, LLC | Pharma Packaging Solutions, LLC dba Tjoapack LLC | Sovereign Pharmaceuticals, LLC | 2023-08-02 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Donnatal | PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDE | Advanz Pharma (US) Corp. | c93cccdc-2f92-4cb3-9d14-06acdd51d94c | 2024-12-05 | Warnings, Adverse reactions | F2R8V82B84 |
| Donnatal | PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDE | Advanz Pharma (US) Corp. | 4dba30db-7979-455f-a225-24f0a04d744e | 2024-12-05 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate | HYOSCYAMINE SULFATE | NCS HealthCare of KY, LLC dba Vangard Labs | fdf1f194-2e18-403c-be28-7dd58739ead7 | 2024-11-13 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate | HYOSCYAMINE SULFATE | NCS HealthCare of KY, LLC dba Vangard Labs | e291da2e-a693-43f5-8cdd-2b8725371b79 | 2024-09-30 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate | HYOSCYAMINE SULFATE | Chartwell RX, LLC | 526399a7-03ea-4d09-8dcd-d5cb012ab5c5 | 2024-09-25 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate | HYOSCYAMINE SULFATE | Patrin Pharma, Inc. | 84be0ac5-f56f-4a06-a923-ca25252c5fef | 2024-09-04 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate | HYOSCYAMINE SULFATE | Patrin Pharma, Inc. | cd79f902-2a7b-4f3f-ac17-beaa254adfbc | 2024-09-04 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate | HYOSCYAMINE SULFATE | Patrin Pharma, Inc. | 56910c34-cf78-4dcd-a594-6efec255e695 | 2024-09-03 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate | HYOSCYAMINE SULFATE | Patrin Pharma, Inc. | d7189f97-d570-4662-8f1d-cf1da02f01ec | 2024-09-03 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine sulfate | HYOSCYAMINE SULFATE | Chartwell RX, LLC | 342edf8e-cca5-4018-9373-0b2e62bc9f4b | 2024-06-07 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyosyne | HYOSCYAMINE SULFATE | Lannett Company, Inc. | a0e8f7d7-9316-4b78-acc8-17519b9b3165 | 2024-04-09 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyosyne | HYOSCYAMINE SULFATE | Lannett Company, Inc. | 38f12473-08e0-4970-a6ef-a825cc7de8d8 | 2024-04-09 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate | HYOSCYAMINE SULFATE | Bryant Ranch Prepack | 44119cad-489b-4866-b150-8fbc47f516f6 | 2023-08-31 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate | HYOSCYAMINE SULFATE | Bryant Ranch Prepack | 7258faac-4e08-469b-950c-abe5a5f94445 | 2023-08-31 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate | HYOSCYAMINE SULFATE | Bryant Ranch Prepack | db2dc70e-b2ae-4d65-9c2d-ed4bdfb3c0e7 | 2023-08-28 | Warnings, Adverse reactions | F2R8V82B84 |
| 01f8f21e-bfae-e857-e063-6294a90a6be9 | 01f8f21e-bfad-e857-e063-6294a90a6be9 | 2023-08-02 | Warnings, Adverse reactions | 01f8f21e-bfae-e857-e063-6294a90a6be9 01f8f21e-bfad-e857-e063-6294a90a6be9 | ||
| Hyoscyamine ER | HYOSCYAMINE SULFATE | Mylan Pharmaceuticals Inc. | 5bbce8c0-a9c9-45b9-8457-1542bd3d9449 | 2023-07-15 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate | HYOSCYAMINE SULFATE | Bryant Ranch Prepack | 57b26b7f-f22d-4ffb-a748-d430572f92a7 | 2023-04-12 | Warnings, Adverse reactions | F2R8V82B84 |
| Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide | PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDE | Ingenus Pharmaceuticals, LLC | 33bf2df5-bc53-4d57-a9e7-41f3fc0a03f0 | 2023-01-12 | Warnings, Adverse reactions | F2R8V82B84 |
| Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate and Scopolamine Hydrobromide | PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE AND SCOPOLAMINE HYDROBROMIDE | Ingenus Pharmaceuticals, LLC | 0dd71f55-e009-48dd-809d-5f651f7521de | 2023-01-10 | Warnings, Adverse reactions | F2R8V82B84 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.